SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: bio_kruncher who wrote (13254)9/30/2004 4:52:09 PM
From: Biomaven  Read Replies (2) | Respond to of 52153
 
about half of Vioxx use was chronic(a wild guess) - $ 1B annually at $1000/yr cost makes 1M users.

I've seen a figure of 25m Vioxx users ever. That suggests much less chronic use than half, given its sales. Further, not everyone was on the 25mg dose - some were on a lower dose. Still further, the 18 month numbers showed no difference from placebo - that means that only very long term use was at issue.

Peter